Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
4.650
+0.310 (7.14%)
Nov 4, 2024, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for FENC stock have an average target of 14, with a low estimate of 13 and a high estimate of 15. The average target predicts an increase of 201.08% from the current stock price of 4.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 22, 2024.
Analyst Ratings
The average analyst rating for FENC stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +179.57% | Aug 22, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +222.58% | Aug 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +265.59% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +222.58% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +287.10% | Apr 4, 2024 |
Financial Forecast
Revenue This Year
56.70M
from 21.25M
Increased by 166.78%
Revenue Next Year
58.10M
from 56.70M
Increased by 2.47%
EPS This Year
0.19
from -0.60
EPS Next Year
0.27
from 0.19
Increased by 38.40%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 63.0M | 73.3M | 122.0M | ||
| Avg | 56.7M | 58.1M | 97.3M | ||
| Low | 49.2M | 44.2M | 57.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 196.2% | 29.4% | 109.9% | ||
| Avg | 166.8% | 2.5% | 67.4% | ||
| Low | 131.3% | -22.1% | -1.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.46 | 0.98 | 2.46 | ||
| Avg | 0.19 | 0.27 | 1.66 | ||
| Low | -0.02 | -0.19 | 0.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 409.2% | 825.8% | ||
| Avg | - | 38.4% | 526.4% | ||
| Low | - | - | -11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.